Description
Clindamycin is a lincosamide antibiotic that exhibits antibacterial, anti-protozoan, anti-parasitic, and antimalarial activities. Clindamycin displays efficacy against anaerobic gram negative bacteria, Streptococcus, and Staphylococcus (particularly MRSA). Clindamycin binds 23S rRNA of the ribosomal 50S subunit, preventing translocation and protein synthesis. When co-administered with other anti-parasitic compounds, clindamycin is also occasionally used to treat Plasmodium infection.